Authors:
Ideker, RE
Alferness, C
Melnick, S
Sreenan, KM
Johnson, E
Smith, WM
Citation: Re. Ideker et al., Reentry site during fibrillation induction in relation to defibrillation efficacy for different shock waveforms, J CARD ELEC, 12(5), 2001, pp. 581-591
Citation: Wm. Smith et Rc. Barr, The forward and inverse problems: What are they, why are they important, and where do we stand?, J CARD ELEC, 12(2), 2001, pp. 253-255
Citation: Lp. Weng et al., PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and 1RS-1/Grb-2/Sos complex formation in a breast cancer model, HUM MOL GEN, 10(6), 2001, pp. 605-616
Authors:
Cates, AW
Smith, WM
Ideker, RE
Pollard, AE
Citation: Aw. Cates et al., Purkinje and ventricular contributions to endocardial activation sequence in perfused rabbit right ventricle, AM J P-HEAR, 281(2), 2001, pp. H490-H505
Authors:
Smith, WM
Zhou, XP
Kurose, K
Gao, X
Latif, F
Kroll, T
Sugano, K
Cannistra, SA
Clinton, SK
Maher, ER
Prior, TW
Eng, C
Citation: Wm. Smith et al., Opposite association of two PPARG variants with cancer: overrepresentationof H449H in endometrial carcinoma cases and underrepresentation of P12A inrenal cell carcinoma cases, HUM GENET, 109(2), 2001, pp. 146-151
Authors:
Huang, J
Rogers, JM
Killingsworth, CR
Walcott, GP
KenKnight, BH
Smith, WM
Ideker, RE
Citation: J. Huang et al., Improvement of defibrillation efficacy and quantification of activation patterns during ventricular fibrillation in a canine heart failure model, CIRCULATION, 103(10), 2001, pp. 1473-1478
Citation: Wm. Smith, The treatment of mild essential hypertension: The US Public Health ServiceHospitals clinical trial, CLINICAL TRIALS IN HYPERTENSION, 2001, pp. 11-25
Authors:
Probstfield, JL
Applegate, WB
Berge, KE
Cutler, JA
Davis, B
Furberg, CD
Hawkins, CM
Pressel, S
Schron, EB
Smith, WM
Citation: Jl. Probstfield et al., Systolic Hypertension in the Elderly Program (SHEP): The first demonstration that lowering systolic hypertension reduced total stroke and all coronary heart disease, CLINICAL TRIALS IN HYPERTENSION, 2001, pp. 195-231
Authors:
Zheng, XS
Walcott, GP
Hall, JA
Rollins, DL
Smith, WM
Kay, GN
Ideker, RE
Citation: Xs. Zheng et al., Electrode impedance: An indicator of electrode-tissue contact and lesion dimensions during linear ablation, J INTERV C, 4(4), 2000, pp. 645-654
Authors:
Reed, T
Carmelli, D
Swan, GE
Wolf, PA
Miller, BL
Krasnow, R
Smith, WM
Citation: T. Reed et al., Ten-year follow-up for male twins divided into high- or low-risk groups for ischemic heart disease based on risk factors measured 25 years previously, ANN EPIDEMI, 10(5), 2000, pp. 278-284
Authors:
Zhang, S
Skinner, JL
Sims, AL
Rollins, DL
Walcott, GP
Smith, WM
Ideker, RE
Citation: S. Zhang et al., Three-dimensional mapping of spontaneous ventricular arrhythmias in a canine thrombotic coronary occlusion model, J CARD ELEC, 11(7), 2000, pp. 762-772
Citation: Mm. Ward et al., A comparison of three approaches for attributing hospitalizations to specific diseases in cost analyses, INT J TE A, 16(1), 2000, pp. 125-136
Authors:
Smith, WM
Vidaillet, HJ
Worley, SJ
Pollard, JK
German, LD
Mortara, DW
Ideker, RE
Citation: Wm. Smith et al., Signal averaging in Wolff-Parkinson-White syndrome: Evidence that fractionated activation is not necessary for body surface high frequency potentials, PACE, 23(9), 2000, pp. 1330-1335
Authors:
Zhou, XP
Smith, WM
Gimm, O
Mueller, E
Gao, X
Sarraf, P
Prior, TW
Plass, C
von Deimling, A
Black, PM
Yates, AJ
Eng, C
Citation: Xp. Zhou et al., Over-representation of PPAR gamma sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general population, J MED GENET, 37(6), 2000, pp. 410-414
Authors:
Young, MT
Blanchard, SM
White, MW
Johnson, EE
Smith, WM
Ideker, RE
Citation: Mt. Young et al., Using an artificial neural network to detect activations during ventricular fibrillation, COMPUT BIOM, 33(1), 2000, pp. 43-58